Clinical Laboratory Improvement Amendments (CLIA) has not impeded patient access to tests says Office of Inspector General (OIG)
This article was originally published in Clinica
Executive Summary
Within the next few months, the US Department of Health & Human Services (HHS) Office of Inspector General (OIG) will announce that strict new rules and federal regulation of clinical laboratories have apparently not limited patient access to certain tests, reports Clinica's Washington correspondent, Duffy Miller.